Literature DB >> 22734619

Hepatic protein expression networks associated with masculinization in the female fathead minnow (Pimephales promelas).

Christopher J Martyniuk1, Sophie Alvarez, Bonnie P Lo, James R Elphick, Vicki L Marlatt.   

Abstract

Endocrine disruptors that act via the androgen receptor (AR) are less well studied than environmental estrogens, and there is evidence that treatment with AR agonists can result in masculinization of female fish. In this study, female fathead minnows (FHM) were exposed to the model nonaromatizable androgen 5-alpha dihydrotestosterone (DHT) (100 μg/L), the ureic-based herbicide linuron (LIN) (100 μg/L), and a mixture of DHT and LIN (100 μg/L each) to better characterize androgen action in females. LIN was used because of reports that this chemical has an antiandrogenic mode of action in fish. After 21d, DHT and LIN treatments resulted in a significant depression of plasma vitellogenin (Vtg) and DHT and DHT+LIN increased the prevalence of nuptial tubercles in female FHMs indicating masculinization. Using iTRAQ and an LTQ Orbitrap Velos, ∼2000 proteins were identified in the FHM liver and the number of proteins quantified after exposures was >1200. Proteins that significantly and consistently changed in abundance across biological replicates included prostaglandin E synthase 3, programmed cell death 4a, glutathione S transferases, canopy, selenoprotein U, and ribosomal proteins. Subnetwork enrichment analysis identified that interferon and epidermal growth factor signaling were regulated by DHT and LIN, suggesting that these signaling pathways are correlated to depressed plasma vitellogenin. These data provide novel insight into hepatic protein networks that are associated with the process of masculinization in teleosts.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22734619     DOI: 10.1021/pr3002468

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  7 in total

1.  Sexually dimorphic transcriptomic responses in the teleostean hypothalamus: a case study with the organochlorine pesticide dieldrin.

Authors:  Christopher J Martyniuk; Nicholas J Doperalski; Kevin J Kroll; David S Barber; Nancy D Denslow
Journal:  Neurotoxicology       Date:  2012-10-03       Impact factor: 4.294

2.  Protein targets of acrylamide adduct formation in cultured rat dopaminergic cells.

Authors:  Christopher J Martyniuk; April Feswick; Bin Fang; John M Koomen; David S Barber; Terrence Gavin; Richard M Lopachin
Journal:  Toxicol Lett       Date:  2013-04-06       Impact factor: 4.372

3.  Comparative proteomics analysis of teleost intermuscular bones and ribs provides insight into their development.

Authors:  Chun-Hong Nie; Shi-Ming Wan; Tea Tomljanovic; Tomislav Treer; Chung-Der Hsiao; Wei-Min Wang; Ze-Xia Gao
Journal:  BMC Genomics       Date:  2017-02-10       Impact factor: 3.969

4.  Secretoneurin A regulates neurogenic and inflammatory transcriptional networks in goldfish (Carassius auratus) radial glia.

Authors:  Dillon F Da Fonte; Christopher J Martyniuk; Lei Xing; Adrian Pelin; Nicolas Corradi; Wei Hu; Vance L Trudeau
Journal:  Sci Rep       Date:  2017-11-02       Impact factor: 4.379

5.  Meta-type analysis of dopaminergic effects on gene expression in the neuroendocrine brain of female goldfish.

Authors:  Jason T Popesku; Christopher J Martyniuk; Vance L Trudeau
Journal:  Front Endocrinol (Lausanne)       Date:  2012-11-02       Impact factor: 5.555

6.  Gene expression networks underlying ovarian development in wild largemouth bass (Micropterus salmoides).

Authors:  Christopher J Martyniuk; Melinda S Prucha; Nicholas J Doperalski; Philipp Antczak; Kevin J Kroll; Francesco Falciani; David S Barber; Nancy D Denslow
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

7.  Metabolic consequences of microRNA-122 inhibition in rainbow trout, Oncorhynchus mykiss.

Authors:  Jan A Mennigen; Christopher J Martyniuk; Iban Seiliez; Stéphane Panserat; Sandrine Skiba-Cassy
Journal:  BMC Genomics       Date:  2014-01-27       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.